Janus Henderson Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,276
Closed -$1.29M 2575
2024
Q4
$1.29M Hold
25,276
﹤0.01% 1550
2024
Q3
$1.04M Hold
25,276
﹤0.01% 1645
2024
Q2
$1.22M Sell
25,276
-251
-1% -$11.1K ﹤0.01% 1518
2024
Q1
$1.22M Buy
25,527
+1
+0% +$53 ﹤0.01% 1536
2023
Q4
$1.66M Sell
25,526
-2,838
-10% -$171K ﹤0.01% 1342
2023
Q3
$1.85M Buy
28,364
+8,209
+41% +$516K ﹤0.01% 1232
2023
Q2
$1.17M Hold
20,155
﹤0.01% 1526
2023
Q1
$1.24M Buy
20,155
+12,783
+173% +$767K ﹤0.01% 1506
2022
Q4
$468K Hold
7,372
﹤0.01% 1745
2022
Q3
$536K Sell
7,372
-944
-11% -$70.3K ﹤0.01% 1919
2022
Q2
$565K Buy
8,316
+4,273
+106% +$307K ﹤0.01% 1697
2022
Q1
$366K Sell
4,043
-66,959
-94% -$5.48M ﹤0.01% 2103
2021
Q4
$6.48M Buy
71,002
+4,364
+7% +$374K ﹤0.01% 1008
2021
Q3
$5.4M Sell
66,638
-13,207
-17% -$1.11M ﹤0.01% 1039
2021
Q2
$7.45M Buy
+79,845
New +$7.74M ﹤0.01% 985

Other funds holding NARI

Janus Henderson Group's NARI Position: Q1 2025 in Review

Janus Henderson Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 25,276 shares — an estimated $1.29M sold.

Janus Henderson Group first reported a position in NARI in Q2 2021 and held it in 15 quarters. The position peaked at $7.45M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Janus Henderson Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 25,276 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.29M.
  • Janus Henderson Group first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Janus Henderson Group's Inari Medical, Inc. Common Stock position peaked at $7.45M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.